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Abstract:  Rutin (1), rutin 3'-methyl ether (2), and a new flavonol glycoside, 6-hydroxy-rutin 3',7-dimethyl ether 
(3), were isolated from the methanol extract of the fruits of Ruta chalepensis, collected from Diyala, Iraq. Their 
structures were elucidated by spectroscopic analyses, including 1D-, 2D-NMR and HRESIMS. Antimicrobial 
activity of compounds 1-3 was tested against four Gram +ve and Gram –ve bacterial strains, and the only fungal 
strain, Candida albicans, using the 96-well based resazurin microtitre assay. 
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1. Introduction 
Ruta chalepensis L. (family: Rutaceae), commonly known as “fringed rue”, is a perennial herb 
(ca. 80 cm tall), native to Eurasia and North Africa and introduced elsewhere [1-4].  Different parts of 
this plant have been used for centuries in traditional medicine to treat convulsions, dropsy, fever, 
mental disorders, menstrual problems, neuralgia, rheumatism, and other bleeding and nervous 
disorders [2, 4-6]. Whilst previous phytochemical studies on this plant revealed the presence of several 
alkaloids, anthraquinones, cardiac glycosides, coumarins, flavonoids, saponins, tannins and terpenoids 
[3, 4, 7-10], pharmacological evaluations established its analgesic, anthelmintic, anti-
acetylcholinesterase, anticancer, anti-inflammatory, antimicrobial, antioxidant and antiparasitic 
properties [1, 5-8, 11-15]. We now report on the isolation, characterization and antimicrobial activity 
of three flavonol glycosides (1-3) (Figure 1) including a new one, 6-hydroxy-rutin 3',7-dimethyl ether 
(3) from the fruits of R. chalepensis, collected in Iraq.  
2. Materials and Methods 
2.1. General  
Chromatographic solvents were purchased from Fisher Scientific, UK, and used without further 
purification. The NMR spectroscopic analyses were performed on a Bruker AMX600 NMR 
spectrometer (600 MHz for 1H, and 150 MHz for 13C). MS analyses were performed on a Xevo G2-S 
ASAP or LTQ Orbitrap XL 1 spectrometers. UV spectra were recorded on Analytik Jena Specord 210 
spectrophotometer. The SPE fractions were analysed on a Dionex Ultimate 3000 UHPLC coupled 
with a photodiode array (PDA) detector, using a Phenomenex Gemini-NX 5 U C18 column (150 × 4.6 
mm, 5 m, Phenomenex, USA) and gradient solvent systems comprising MeOH (solvent B) and water 
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(solvent A) (both contained 0.1% TFA, flow rate: 1 mL/min) were employed to optimize separation of 
compounds for preparative HPLC. An Agilent 1260 Infinity series preparative HPLC coupled with a 
PDA detector was used to isolate compounds on an ACE preparative column (150 × 21.2 mm, 5 m, 
Hichrom Ltd, UK; MeOH-water linear gradient, flow rate: 10 mL/min). The column temperature was 
set at 25 °C. The chromatogram was monitored at variable UV–vis wavelengths (215, 254, 280 and 
320 nm).  
 
Compounds R R' R'' 
Rutin (1) H H H 
Rutin 3'-methyl ether (2) Me H H 
6-Hydroxy-rutin 3'-7-dimethyl ether (3) Me Me OH 
 
Figure 1.  Structures of flavonol glycosides 1-3 
 
2.2 Plant Materials 
The fruits of R. chalepensis L. were collected from Diyala, Central Iraq (N 33.79684 E 
44.623337) in September 2015, air-dried at room temperature, and ground using a coffee grinder.  A 
voucher specimen (33396) for this collection has been retained at the National Herbarium of Iraq. 
 
2.3. Extraction and Isolation 
 Ground air-dried fruits (103 g) were Soxhlet-extracted, successively, with n-hexane, 
dichloromethane (DCM) and methanol (MeOH) (0.9 L, 10 cycles each).  All extracts were evaporated 
to dryness using a rotary evaporator at 45oC to obtain 4.6 g, 4.2 g and 6.0 g of n-hexane, DCM and 
MeOH extracts, respectively. A portion (2 g) of the active MeOH extract was subjected to solid-phase 
extraction (SPE) on a Strata (20 g, Phenomenex) C18 reversed-phase cartridge eluted with water-
MeOH mixture of decreasing polarity, water:MeOH 80:20, 50:50, 20:80 and 0:100 (250 mL each), to 
obtain four SPE fractions I-IV, respectively. All SPE fractions were dried using a rotary evaporator 
followed by freeze-drying and stored in sealed vials in a fridge for further work. Reversed-phase 
preparative HPLC purification of the SPE fraction II (linear gradient: solvent B in A, 30-100% in 30 
min) afforded compounds 1 (3.5 mg, tR = 15.9 min), 2 (2.1 mg, tR = 17.1 min) and 3 (3.2 mg, tR = 18.0 
min), respectively.   
 
2.3.1. Rutin (1) 
 Yellow amorphous solid; UV max (MeOH) nm: 257, 267 (sh), 300 (sh) and 359 nm; 1H NMR 
(CD3OD, 600 MHz), see Table 1; 13C NMR (CD3OD, 150 MHz), see Table 2; HRESIMS (negative 
ion mode) m/z 609.1456 [M-H]-, (calcd. for C27H29O16, m/z 609.1456) [16]. 
 
2.3.2. Rutin 3'-methyl ether (2) 
 Brown amorphous solid; UV max (MeOH) nm: 254, 264 (sh), 304 (sh) and 354 nm; 1H NMR 
(CD3OD, 600 MHz), see Table 1; 13C NMR (CD3OD, 150 MHz), see Table 2; HRESIMS (positive ion 
mode) m/z 625.1761[M+H]+ (calcd. for C28H33O16, m/z 625.1769) [16-18]. 
 
2.3.3. 6-Hydroxy-rutin 3',7-dimethyl ether (3) 
 Brown amorphous solid; UV max (MeOH) nm: 252, 260 (sh), 306 (sh) and 360 nm; 1H NMR 
(CD3OD, 600 MHz), see Table 1; 13C NMR (CD3OD, 150 MHz), see Table 2; HRESIMS (positive ion 
mode) m/z 655.1870 [M+H]+ (calcd. for C29H35O17, m/z 655.1874). 
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2.4. Antimicrobial Assay (Resazurin Assay) 
All three compounds (1-3) were screened for their potential antimicrobial activity against four 
bacterial strains, e.g., Gram +ve: Micrococcus luteus (NCTC 7508) and Staphylococcus aureus 
(NCTC 12981) and Gram –ve:  Escherichia coli (NCTC12241) and Pseudomonas aeruginosa (NCTC 
12903), and a fungal strain, Candida albicans (ATCC 90028) using the resazurin 96-well microtitre 
plate-based in vitro antimicrobial assay [19]. All bacterial strains were cultured on nutrient agar 
(Oxoid) and incubated for 24h at 37oC to determinate the MIC. Ciprofloxacin was used as a positive 
control for bacterial strains, and nystatin for C. albicans. Resazurin solution, prepared by dissolving 1 
mg of resazurin in 5 mL of sterile distilled water, was used in this assay as an indicator of cell growth, 
and the method was as described by Sarker et al. [19]. This experiment was performed under aseptic 
conditions using a sterile 96 well plate. Compound solution (100 μL) was added into the first row of 
the plate and 50 μL of normal saline was added to all other wells. Serial dilutions were achieved using 
a multichannel pipette. To each well, 30 μL of nutrient broth and 10 μL of resazurin indicator solution 
were added. Finally, 10 μL of bacterial suspension (5×105 cfu/mL) was added to each well. To 
prevent bacterial dehydration, each plate was wrapped loosely with cling film. Every plate contained a 
positive control. Any colour changes (or no changes in positive control), blue to pink, were noted. The 
lowest concentration was taken in the colour change that occurred as an MIC (minimum inhibitory 
concentration) value. The mean of three values was calculated. 
 
2.4.1. Determination of bacteriostatic or bactericidal property 
 To determine whether the compounds were bacteriostatic or bactericidal, under aseptic 
condition, 100 L of culture from the rows of MIC in the microtitre plates was transferred to an empty 
petri dish, 20 mL of nutrient agar was poured on to the dish, and incubated at 37oC for 24 h. Any 
microbial regrowth indicated bacteriostatic, and no growth indicated bactericidal activity of the test 
sample.  
 
3.  Results and Discussion  
 
3.1. Extraction, Isolation and Structure Elucidation of Rutin Derivatives (1-3) 
Soxhlet extraction of the dried and ground fruits of Ruta chalepensis afforded 4.6, 4.2 and 6.0 
g of n-hexane, DCM and MeOH extracts, respectively. SPE of the MeOH extract, the most active 
extract of the three, produced 0.45, 0.49, 0.50 and 0.40 g of SPE fractions, eluted with 20, 50, 80 and 
100% MeOH in water, indicating an excellent recovery of the sample from the SPE cartridge. 
Antimicrobial assay-guided and preparative HPLC-assisted purification of the most active SPE 
fraction II afforded compounds 1-3. The UV-Vis spectral analyses of the compounds 1-3 indicated 
that they were flavonoid glycosides, possibly with rutin-type skeleton [18]. The HRESIMS analyses of 
these compounds (1-3) provided their molecular formula, C27H30O16, C28H32O16 and C29H34O17, 
respectively, suggesting compound 1 could be rutin.  It also added further evidence to the assumption 
made from the UV-Vis data that compounds 1-3 could be rutin derivatives. In fact, according to the 
HRESIMS data, compound 2 had just 14 amu unit more than that of rutin (1) suggesting this 
compound could be a methyl ether of rutin (1). Similarly, the molecular mass of compound 3 was 44 
amu unit higher than that of rutin (1), indicating this compound could be a dimethyl ether analogue of 
1 with an additional hydroxyl group. The 1H and 13C NMR data (Tables 1 and 2) of compounds 1 and 
2 were in good agreement with respective published data for rutin (1) and rutin 3'-methyl ether (2) [16-
18]. The attachment of the rutinosyl moiety at C-3 in compounds 1 and 2, and the methyl ether 
formation at C-3' in compound 2 were confirmed from extensive HSQC and HMBC experiments. 
The 1H NMR spectrum (Table 1) of compound 3 was quite similar to that of compound 2, with 
the exception that there was a downfield 6H singlet at 3.97, and instead of the usual shielded 
aromatic meta-coupled proton signals for H-6 and H-8 in flavonol skeleton, there was only a 1H 
singlet at 6.53 suggesting that one of those protons was substituted by an extra functional group, most 
likely a hydroxyl group based on the HRESIMS data. The 13C NMR spectrum of 3 (Table 2) showed 
the presence of an additional oxygenated aromatic quaternary signal at 145.3, which could be 
assigned to C-6 or C-8. Whilst a COSY experiment of compound 3 established all major 1H-1H scalar 
couplings, 1H-13C direct (1J) couplings weres obtained from an HSQC experiment confirming the 
Author et.al., Rec. Nat. Prod. (20XX) X:X XX-XX 
 
179 
assignment of all protonated 13C signals to their respective 1H signals. An HMBC experiment 
displayed all major 1H-13C long-range (2J and 3J) correlations (Figure 2). The rhamnose anomeric 
proton (H-1''') showed a 3J correlation to C-6''' of the glucose unit, and the glucose anomeric proton 
(H-1'') displayed a 3J correlation to C-3 of the flavonol aglycones, confirming the formation of the 
disaccharide, rutinose, and its connection to C-3 (as in compounds 1 and 2). Similarly, 3J correlations 
from the methoxyl signal at 3.97 (6H) (Table 1) to C-7 and C-3' (Table 2) established methyl ether 
formation at C-7 and C-3' (Figure 2). The 13C NMR (Table 2) signal at 96.4 confirmed that the 
hydroxylation was indeed on C-6 in compound 3, and this fact was further corroborated from the 1H-
13C HMBC long-range correlations from H-8 signal to C-6 and C-10 (Figure 2). Thus, the compound 3 
was identified as 6-hydroxy-rutin 3',7-dimethyl ether (3), which to the best of our knowledge, is a new 
natural product. This is also the first report on any assay-guided phytochemical analysis of the fruits of 
Iraqi R. chalepensis. 
   
Table 1. 1H NMR data for compounds 1-3 (at 600 MHz in CD3OD,  in ppm, J in Hz) 
 
Position (H) 1 2 3 
Aglycone    
6 6.23 (1H, d, J = 2.1) 6.23 (1H, d, J = 2.0) - 
8 6.42 (1H, d, J = 2.1) 6.44 (1H, d, J = 2.0) 6.53 (1H, s) 
2' 7.69 (1H, d, J = 2.0) 7.96 (1H, d, J = 2.0) 8.00 (1H, d, J = 2.0) 
5' 6.89 (1H, d, J = 8.4) 6.94 (1H, d, J = 8.4) 6.94 (1H, d, J = 8.4) 
6' 7.65 (1H, dd, J = 2.0, 8.4) 7.65 (1H, dd, J = 2.0, 8.4) 7.80 (1H, dd, J = 2.0, 8.4) 
7-OMe - - 3.97 (3H, s) 
3'-OMe - 3.97 (3H, s) 3.97 (3H, s) 
Glucose moiety    
1'' 5.12 (1H, d, J = 7.7) 5.25 (1H, d, J = 7.6) 5.25 (1H, d, J = 7.4) 
2'' 3.49* 3.49* 3.49* 
3'' 3.31* 3.32* 3.31* 
4'' 3.29* 3.30* 3.29* 
5'' 3.43* 3.46* 3.43* 
6'' 3.41* 
3.81 (1H, m) 
3.44* 
3.84 (1H, m) 
3.44* 
3.84 (1H, m) 
Rhamnose moiety    
1''' 4.54 (1H, d, J = 1.5) 4.55 (1H, d, J = 1.5) 4.54 (1H, d, J = 1.4) 
2''' 3.65* 3.63* 3.60* 
3''' 3.55* 3.56* 3.54* 
4''' 3.30* 3.28* 3.28* 
5''' 3.46* 3.43* 3.43* 
6''' 1.14 (3H, d, J = 6.2) 1.11 (3H, d, J = 6.2) 1.11 (3H, d, J = 6.3) 
 
*Overlapped peaks – confirmed from COSY. HSQC and HMBC experiments 
 
3.2 Antimicrobial activity 
Potential antimicrobial properties of rutin (1) and its two derivatives (2 and 3) were assessed 
against two Gram +ve, two Gram –ve bacterial species, and a fungal strain (Table 3). All compounds 
(1-3) showed various degrees of activities against all tested organisms in the resazurin microtitre assay 
[19]. Among three compounds, compound 3 was the most potent one, and the order of antimicrobial 
potency among these compounds was 3>2>1, which indicated that the addition of methyl ether 
functionality on rutin (1) enhanced the potency; more the number of methoxyl groups, the better was 
the activity. In fact, the cell membrane is considered as a direct target of antibacterial action of 
flavonoids, suggesting that membrane interaction could be an important mechanism of antibacterial 
activity of flavonoids, and increased lipophilicity in flavonoids might lead to enhanced membrane 
interaction [20]. All three compounds were particularly active against the fungal strain Candida 
albicans (MICs = 96-205 M). Ruta chalepensis has long been used in Iraqi traditional medicine to 
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treat various diseases including microbial infections [3,4]. Antimicrobial assay-guided isolation of 
rutin (1) and its derivatives (2 and 3) as active components and subsequent assessment of their 
antimicrobial properties have provided some scientific evidence for the traditional use of R. 
chalepensis to treat infections.   
 
Table 2. 13C NMR data for compounds 1-3 (at 150 MHz in CD3OD,  in ppm) 
 
Position (C) 1 2 3 
Aglycone    
2 159.5 159.0 159.3 
3 135.7 135.6 135.3 
4 179.5 179.5 180.0 
5 163.2 163.2 153.2 
6 100.0 100.1 127.8 
7 166.2 166.2 155.5 
8 95.0 95.0 96.4 
9 158.5 158.7 145.3  
10 105.7 105.9 106.0 
1' 123.2 123.2 123.3 
2' 117.8 114.7 114.8 
3' 146.0 148.5 148.5 
4' 150.4 151.0 151.0 
5' 116.2 116.3 116.2 
6' 123.7 124.2 124.7 
7-OMe - - 57.2 
3'-OMe - 56.9 56.9 
Glucose moiety    
1'' 104.8 104.5 104.5 
2'' 75.9 76.1 76.1 
3'' 77.4 72.4 72.4 
4'' 71.5 77.5 77.5 
5'' 78.3 78.3 78.3 
6'' 68.7 68.1 68.7 
Rhamnose moiety    
1''' 102.5 102.7 102.7 
2''' 72.2 72.2 72.2 
3''' 72.4 71.8 71.8 
4''' 74.1 74.0 74.0 
5''' 69.8 69.9 69.9 
6''' 18.0 18.0 18.0 
 
 
Table 3. Antimicrobial activity of compounds 1-3 
 
Test organisms Minimum inhibitory concentration (MIC) in M 
Positive controls Compounds 
Ciprofloxacin Nystacin 1 2 3 
Escherichia coli (NCTC 12241) 1.473 N/A 1638.9 1601.2 774.5 
Micrococcus luteus (NCTC 7508) 2.947 N/A 409.7 200.1 193.6 
Pseudomonas aeruginosa (NCTC 12903) 7.36 x 10-1 N/A 1638.9 800.6 387.3 
Staphylococcus aureus (NCTC 12981) 2.947 N/A 1638.9 1601.2 1459.1 
Candida albicans (ATCC 90028) N/A 1.054 204.9 100.1 96.8 
   
 




Figure 2. 1H-13C HMBC selected long-range key correlations of compound 3  
 
Rutin (1) is one of the most common flavonol glycosides, especially found in the plants from the 
family Rutaceae, and has been extensively studied to establish its various bioactivities including 
antibacterial and antifungal properties [16, 21-23]. Therefore, the antimicrobial activities of rutin (1) 
and its analogues (2 and 3), including a new one (3), as observed in the present study, are in agreement 
with previous reports [16, 21-23]. All these compounds (1-3) were found to be bacteriostatic [24,25] 
as there was microbial regrowth, when under aseptic condition, 100 L of culture from the rows of 
MIC in the microtitre plates was transferred to an empty petri dish, 20 mL of nutrient agar was added, 
and incubated at 37oC for 24 h.  
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